Summit Financial’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$346K	Buy	126,373 +19,110	+18%	+$60.5K	﹤0.01%	1126
2025 Q4	$397K	Buy	107,263 +8,625	+9%	+$27.9K	0.01%	963
2025 Q3	$261K	Buy	98,638 +23,853	+32%	+$46.1K	﹤0.01%	1113
2025 Q2	$74.3K	Buy	74,785 +9,591	+15%	+$9.6K	﹤0.01%	807
2025 Q1	$93.9K	Buy	65,194 +18,666	+40%	+$34.4K	﹤0.01%	703
2024 Q4	$102K	Buy	46,528 +7,150	+18%	+$16.7K	﹤0.01%	630
2024 Q3	$65K	Buy	39,378 +6,691	+20%	+$13.5K	﹤0.01%	539
2024 Q2	$72.6K	Buy	32,687 +6,823	+26%	+$16.1K	﹤0.01%	487
2024 Q1	$69.3K	Buy	25,864 +10,355	+67%	+$25.2K	﹤0.01%	381
2023 Q4	$46.4K	Buy	15,509 +3,622	+30%	+$4.7K	﹤0.01%	350
2023 Q3	$11.6K	Buy	+11,887	New	+$17.2K	﹤0.01%	330